Sp794

SURVEILLANCE FOR LOW RISK IPMNS Q&A

Date
May 20, 2024

Presenters

Speaker Image for James Farrell
Yale University School of Medicine
Speaker Image for Walter Park
Stanford University

Tracks

Related Products

Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
For years, presentations at DDW focused on endoscopic diagnosis of pancreatic cystic neoplasms. There has been a recent surge of published studies testing various interventions for treating cystic neoplasms (endoscopic ultrasound-guided)…
Thumbnail for SURVEILLANCE FOR LOW RISK IPMNS: PLEASE STOP
Thumbnail for MULTI-CENTER BLINDED VALIDATION OF THE DIAGNOSTIC UTILITY OF CYST GLUCOSE AND AMPHIREGULIN TO DIFFERENTIATE MUCINOUS FROM NON-MUCINOUS PANCREATIC CYSTS.
MULTI-CENTER BLINDED VALIDATION OF THE DIAGNOSTIC UTILITY OF CYST GLUCOSE AND AMPHIREGULIN TO DIFFERENTIATE MUCINOUS FROM NON-MUCINOUS PANCREATIC CYSTS.
BACKGROUND AND AIMS: Currently, most patients with branch duct intraductal papillary mucinous neoplasms (BD-IPMN) are offered indefinite surveillance, resulting in health care costs with questionable benefits regarding cancer prevention…
Thumbnail for TEMPORAL TRENDS IN QUALITY OF LIFE IN A US COHORT OF PATIENTS WITH CHRONIC PANCREATITIS
TEMPORAL TRENDS IN QUALITY OF LIFE IN A US COHORT OF PATIENTS WITH CHRONIC PANCREATITIS
OBJECTIVE. Chronic Pancreatitis (CP) has a detrimental impact on quality of life (QOL). However, with one exception, literature on QOL in CP is limited to cross-sectional data, hindering our ability to understand temporal changes and identify potentially modifiable factors…